Literature DB >> 11035100

Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.

Z You1, X F Huang, J Hester, L Rollins, C Rooney, S Y Chen.   

Abstract

Efficient Ag presentation is essential to induce effective cellular and humoral immune responses. Thus, one central goal of current immunotherapy and vaccine development is to enhance Ag presentation to induce potent and broad immune responses. Here, a novel Ag presentation strategy is developed by transducing dendritic cells (DCs) to produce an Ag for presentation as an exogenous Ag to efficiently induce both humoral and cellular immunity. The principle of this strategy is illustrated by genetically modifying DCs to secrete a model hepatitis B virus Ag fused with a cell-binding domain and to process the fusion Ag as an exogenous Ag after receptor-mediated internalization for MHC class I and II presentation. Vigorous Ag-specific CD4(+) helper and CD8(+) cytotoxic T cell, as well as B cell, responses were induced by the transduced DCs in mouse models. Thus, this novel strategy uses a receptor-mediated internalization process to efficiently induce all arms of the adaptive immunity and may provide a powerful means to develop potent vaccines and immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035100     DOI: 10.4049/jimmunol.165.8.4581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity.

Authors:  Shenghe Tian; Zuqiang Liu; Cara Donahue; Louis D Falo; Zhaoyang You
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

2.  Dendritic cells and the handling of antigen.

Authors:  F Dieli
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

3.  SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.

Authors:  Kevin Evel-Kabler; Xiao-Tong Song; Melissa Aldrich; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

4.  Study on biological characters of SGC7901 gastric cancer cell-dendritic cell fusion vaccines.

Authors:  Kun Zhang; Peng-Fen Gao; Pei-Wu Yu; Yun Rao; Li-Xin Zhou
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

5.  ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.

Authors:  Peter Duewell; Ulrich Kisser; Klaus Heckelsmiller; Sabine Hoves; Patrizia Stoitzner; Sandra Koernig; Adriana B Morelli; Björn E Clausen; Marc Dauer; Andreas Eigler; David Anz; Carole Bourquin; Eugene Maraskovsky; Stefan Endres; Max Schnurr
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

6.  Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency.

Authors:  Qin-Long Gu; Xue Huang; Wen-Hong Ren; Lei Shen; Bing-Ya Liu; Si-Yi Chen
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

7.  Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.

Authors:  Chuan-Lin Ding; Kun Yao; Tian-Tai Zhang; Feng Zhou; Lin Xu; Jiang-Ying Xu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination.

Authors:  Nelson DiPaolo; Shaoheng Ni; Anuj Gaggar; Robert Strauss; Sebastian Tuve; Zong Yi Li; Daniel Stone; Dmitry Shayakhmetov; Nancy Kiviat; Papa Touré; Salif Sow; Branka Horvat; André Lieber
Journal:  Mol Ther       Date:  2006-02-07       Impact factor: 11.454

9.  Transcriptional IL-15-directed in vivo DC targeting DNA vaccine.

Authors:  S Tian; Z Liu; C Donahue; H S Noh; L D Falo; Z You
Journal:  Gene Ther       Date:  2009-09-03       Impact factor: 5.250

10.  A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention.

Authors:  Jie Chen; Hui Liu; Tiffany Jehng; Yanqing Li; Zhoushi Chen; Kuan-Der Lee; Hsieh-Tsung Shen; Lindsey Jones; Xue F Huang; Si-Yi Chen
Journal:  Cancers (Basel)       Date:  2019-12-01       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.